PARP1 and head and neck squamous cell carcinoma: The in vitro growth inhibition and apoptosis induction by hDT806 in HNSCC were recapitulated in a mouse JUH-029 xenograft model, in which treatment with hDT806 was shown to reduce Ki-67 and increase cleaved PARP proteins using IHC analysis.